Biomarker-guided treatment of heart failure: Still waiting for a definitive answer

Journal of the American College of Cardiology

Volumn 56, Issue 25, 2010, Pages 2101-2104

  Troughton, Richard W ^a   Frampton, Chris M ^a   Nicholls, M Gary ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CARDIOVASCULAR AGENT;

CLINICAL ASSESSMENT; DRUG DOSE TITRATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; HYPOTENSION; MORTALITY; NOTE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; UREMIA;

EID: 78649983509     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.07.034     Document Type: Editorial

References (28)

1. A. Maisel Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design? J Am Coll Cardiol 55 2010 61 64
2. M. Packer Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 108 2003 2950 2953
3. D.R. Murdoch, T.A. McDonagh, and J. Byrne Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy Am Heart J 138 1999 1126 1132
4. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
5. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial J Am Coll Cardiol 55 2010 53 60
6. P. Jourdain, G. Jondeau, and F. Funck Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 2007 1733 1739
7. M. Pfisterer, P. Buser, and H. Rickli BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial JAMA 301 2009 383 392
8. R. Berger, D. Moertl, and S. Peter N-terminal proB-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure: a 3-arm, prospective, randomized pilot study J Am Coll Cardiol 55 2009 645 653
9. J. Fang, G.A. Mensah, J.B. Croft, and N.L. Keenan Heart failure-related hospitalization in the U.S., 1979 to 2004 J Am Coll Cardiol 52 2008 428 434
10. S.A. Hunt ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 e1 e82
11. M.J. Lenzen, E. Boersma, and W.J. Reimer Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur Heart J 26 2005 2706 2713
12. P.J. Hauptman, J.P. Swindle, F.A. Masoudi, and T.E. Burroughs Underutilization of {beta}-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures Circ Cardiovasc Qual Outcomes 3 2010 204 211
13. L.W. Stevenson, and J.K. Perloff The limited reliability of physical signs for estimating hemodynamics in chronic heart failure JAMA 261 1989 884 888
14. W.J. Paulus, and J.J. van Ballegoij Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 55 2010 526 537
15. W.H. Tang, G.S. Francis, and D.A. Morrow National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure Clin Biochem 41 2008 210 221
16. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
17. P. Bettencourt, F. Frioes, and A. Azevedo Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure Int J Cardiol 93 2004 45 48
18. R. Latini, S. Masson, and M. Wong Incremental prognostic value of changes in B-type natriuretic peptide in heart failure Am J Med 119 70 2006 e23 e30
19. R.W. Troughton, A.M. Richards, T.G. Yandle, C.M. Frampton, and M.G. Nicholls The effects of medications on circulating levels of cardiac natriuretic peptides Ann Med 39 2007 242 260
20. F.M. Fruhwald, A. Fahrleitner-Pammer, and R. Berger Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony Eur Heart J 28 2007 1592 1597
21. J.P. Araujo, A. Azevedo, P. Lourenco, F. Rocha-Goncalves, A. Ferreira, and P. Bettencourt Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure Am J Cardiol 98 2006 1248 1250
22. L.W.M. Eurlings, P.E.J. van Pol, and W.E. Kok Management of chronic heart failure guided by individual N-terminal proB-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study J Am Coll Cardiol 56 2010 2090100
23. S. Masson, R. Latini, and I.S. Anand Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
24. J.G. Cleland How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey Eur J Heart Fail 4 2002 243 247
25. G.M. Felker, V. Hasselblad, A.F. Hernandez, and C.M. O'Connor Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
26. P. Porapakkham, P. Porapakkham, H. Zimmet, B. Billah, and H. Krum B-type natriuretic peptide-guided heart failure therapy: a meta-analysis Arch Intern Med 170 2010 507 514
27. R.K. Rogers, G.J. Stoddard, and T. Greene Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea Am J Cardiol 104 2009 689 694
28. M.D. Flather, M.C. Shibata, and A.J. Coats Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225